• No se han encontrado resultados

Hepatitis B virus and hepatitis C virus co infection: additive players in chronic liver disease?

N/A
N/A
Protected

Academic year: 2020

Share "Hepatitis B virus and hepatitis C virus co infection: additive players in chronic liver disease?"

Copied!
8
0
0

Texto completo

Loading

Referencias

Documento similar

Some patients develop chronic infection and suffer no significant liver damage, while others progress quickly to liver cirrhosis and may develop hepatocellular carcinoma.. 10

Several systems, molecules and responses involved in the pathogenesis of the pathological fibrosis of chronic kidney disease (CKD) will be discussed in this review, putting

Antiviral activity of Polyanionic Carbosilane Dendrimers as hepatitis C virus entry inhibitors. (Manuscript

The anti-hepatitis B surface antigen (anti-HBs) and anti-hepatitis A virus (anti-HAV) antibody titres observed following a primary vaccination course with Ambirix are in the range

The duration of the antiviral therapy could compromise the validation of the questionnaire if there were differences between the mean duration treatment, classified according to

Background: Environmental lead and cadmium exposure is associated with higher risk of several age-related chronic diseases, including cardiovascular disease, chronic kidney

George Respiratory Questionnaire and Chronic Obstructive Pulmonary Disease Assessment Test in patients with chronic obstructive pulmonary disease based on correlation and

The aim of this work is to search for immunological genetic markers that can explain the natural evolution of hepatitis C virus infection in the patient coinfected with the